IP Library Patent Application 17626529
Patent Application
App. No. 17/626,529

UTERINE HEMORRHAGE CONTROLLING SYSTEM AND METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/626,529
Abstract

A method of reducing postpartum bleeding includes positioning a device comprising a vacuum element within the uterus; sealing the uterus; activating vacuum in the uterus with the vacuum element of the device while the uterus is sealed; and collapsing the uterus with the vacuum to reduce postpartum bleeding.

Claims (35)

1 - 33 . (canceled)

34 . A method of reducing postpartum bleeding comprising:

positioning a device comprising a vacuum element at least partially within a uterus;

sealing the uterus with a seal of the device;

activating vacuum in the uterus with the vacuum element of the device while the uterus is sealed; and

collapsing endometrial trumpet-shaped arteries at an inner surface of the uterus with the vacuum to reduce postpartum bleeding.

35 . The method of claim 34 , further comprising collapsing the uterus with the vacuum to cause contraction of uterine muscles and reduce postpartum bleeding.

36 . The method of claim 34 , wherein activating vacuum comprises supplying vacuum from a pump at between 1 L/min and 20 L/min.

37 . The method of claim 34 , wherein activating vacuum comprises supplying vacuum from a pump at between 10 L/min and 15 L/min.

38 . The method of claim 34 , wherein activating vacuum comprises producing a pressure of 40-160 mmHg.

39 . The method of claim 34 , wherein activating vacuum comprises producing a pressure of 50-100 mmHg.

40 . The method of claim 34 , wherein activating vacuum comprises producing a pressure of 70-90 mmHg.

41 . The method of claim 34 , wherein sealing the uterus comprises placing the seal in the lower uterus, cervix, vaginal canal, or at the vulva.

42 . The method of claim 34 , wherein sealing the uterus comprises sealing so as to hinder a flow of air into the uterus while vacuum is applied in order to achieve a therapeutic isobaric level of vacuum throughout the uterus.

43 . The method of claim 34 , further comprising maintaining an isobaric condition within the uterus after activating vacuum.

44 . The method of claim 34 , wherein activating vacuum comprises activating with a pump having a vacuum reservoir therein so as to enable a consistent flow of vacuum to the uterus.

45 . The method of claim 34 , further comprising detecting air in a tube connected to the vacuum element to determine if there is a leak in a seal.

46 . The method of claim 34 , further comprising visualizing a flow of blood from the uterus through a translucent or transparent tube connected to the vacuum element.

47 . The method of claim 34 , wherein the steps of positioning, sealing, activating, and collapsing result in stopping postpartum bleeding within 5 hours.

48 . The method of claim 34 , wherein the steps of positioning, sealing, activating, and collapsing result in stopping postpartum bleeding within 2 hours.

49 . The method of claim 34 , further comprising confirming that a cervix is dilated to greater than 3 cm prior to the positioning step.

50 . The method of claim 34 , wherein a leak rate past the seal is less than a pump rate of a pump supplying the vacuum.

51 . A method of reducing postpartum bleeding comprising:

positioning a device comprising a vacuum element at least partially within a uterus;

sealing the uterus with a seal of the device;

activating vacuum in the uterus with the vacuum element of the device while the uterus is sealed;

collapsing the uterus with the vacuum; and

maintaining an isobaric condition within the uterus after activating vacuum to reduce postpartum bleeding.

52 . The method of claim 51 , further comprising confirming that a cervix is dilated to greater than 3 cm prior to the positioning step.

53 . A method of reducing postpartum bleeding comprising:

positioning a device comprising a vacuum element at least partially within a uterus;

sealing the uterus with a seal of the device;

activating vacuum in the uterus with the vacuum element of the device while the uterus is sealed; and

collapsing endometrial trumpet-shaped arteries at an inner surface of the uterus with the vacuum to reduce postpartum bleeding; and

detecting air in a tube connected to the vacuum element to determine if there is a leak in a seal.

Assignments (10)
SECURITY INTEREST Recorded Feb 27, 2026
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073924/0283 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073647/0789 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0021 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0252 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2025
From: NORRED, ALEXANDER JAMES; CARLIN, DAVIS REED; HARPER, GEORGE COCHRAN; LAGREW, DAVID C., JR.; SEGNITZ, JAN; UCHIDA, ANDY; DEGENKOLB, AMELIA MICHELE
To: ALYDIA HEALTH, INC.
Reel/Frame 072514/0704 →
SECURITY INTEREST Recorded May 29, 2024
From: ALYDIA HEALTH, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 067545/0844 →
SECURITY INTEREST Recorded Mar 15, 2023
From: ALYDIA HEALTH, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 062994/0905 →
SECURITY INTEREST Recorded Mar 15, 2023
From: ALYDIA HEALTH, INC.
To: JP MORGAN CHASE BANK, N.A.
Reel/Frame 062994/0933 →
SECURITY INTEREST Recorded Mar 15, 2023
From: ALYDIA HEALTH, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 062994/0955 →